logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Study of employees with anhydride-induced respiratory disease after removal from exposure.

    Article - En anglais

    The purpose of this study was to determine clinical and immunologic status of hexahydrophthalic anhydride (HHPA) employees who have had immunologic respiratory disease and who have been removed from exposure for at least 1 year.

    In a retrospective study, 16 consecutive employees with HHPA-induced immunologic respiratory disease who had been removed from exposure for more than 1 year were evaluated.

    Eleven had asthma, allergic rhinitis, or both ; five had hemorrhagic rhinitis.

    Respiratory symptoms were obtained by physician-administered questionnaire.

    Physical examination, spirometry, and chest film were obtained.

    Antibody against HHPA conjugated to human serum albumin (HHP-HSA) was determined by enzyme-linked immunosorbant assay.

    Symptoms, signs, and pulmonary functions were normalized in all employees.

    There was a decline in antibody titers for both IgE and IgG against HHP-HSA.

    There were no chest film findings attributable to HHPA.

    In this group, there appeared to be no evidence of permanent anatomic sequelae after removal from exposure for at least 1 year.

    Specific antibody was still present, but titers were lower at follow-up than at presentation for a substantial proportion of the sample.

    Mots-clés Pascal : Toxicité, Appareil respiratoire pathologie, Immunopathologie, Homme, Exposition professionnelle, Diagnostic, Exploration clinique, Exploration immunologique, Médecine travail, Séquelle, Benzo[C]furane-1,3-dione(perhydro)

    Mots-clés Pascal anglais : Toxicity, Respiratory disease, Immunopathology, Human, Occupational exposure, Diagnosis, Clinical investigation, Immunological investigation, Occupational medicine, Sequela

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0460641

    Code Inist : 002B03L06. Création : 01/03/1996.